Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS cohort study

Journal of Acquired Immune Deficiency Syndromes

Volumn 26, Issue 1, 2001, Pages 82-92

  Kleeberger, Cynthia A ^a   Phair, John P ^b   Strathdee, Steffanie A ^a   Detels, Roger ^c   Kingsley, Lawrence ^d   Jacobson, Lisa P ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Antiretroviral therapy; Cohort studies; HIV 1; Medication adherence

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; FEMALE; HUMAN; HUMAN CELL; INCOME; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEGRO; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; RECALL; REGRESSION ANALYSIS; SELF REPORT; TREATMENT OUTCOME;

EID: 0035146653     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200101010-00012     Document Type: Article

References (45)

1. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV Infection duration
2. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study
3. Decline in deaths from AIDS due to new antiretrovirals
4. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
5. Antiretroviral therapy for HIV infection in 1997
6. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients
7. Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilege (Agence Nationale de Recherches sur le SIDA 072) Study Team
8. Patient compliance and drug failure in protease inhibitor monotherapy
9. HIV-1 drug resistance in newly infected individuals
10. Reduced antiretroviral drug susceptibility among patients with primary HIV infection
11. Antiretroviral therapy: Factors associated with adherence
12. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy
13. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents January 28, 2000
14. The Multicenter AIDS Cohort Study: Rationale, organization, and selected characteristics of the participants
15. Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study
16. Recent scientific contributions to understanding HIV/AIDS from the Multicenter AIDS Cohort Study
17. Measuring adherence to antiretroviral medications in clinical trials
18. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments
19. The CES-D scale: A self-report depression scale for research in the general population
20. Measuring depressive symptoms in illness populations: Psychometric properties of the CES-D
21. Depressive symptoms as predictors of medical outcomes in HIV infection
22. Normative data for a brief neuropsychological screening battery
23. The rand 36-item health survey 1.0
24. Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program
25. Quality control in the flow of cytometric measurement of T-lymphocyte subsets: The Multicenter AIDS Cohort Study Experience
26. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
27. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
28. Zidovudine adherence among individuals with HIV infection
29. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus type 1: A cross-sectional study in a municipal hospital clinic
30. Adherence to highly active antiretroviral therapy
31. Potential factors affecting adherence with HIV therapy
32. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease
33. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance
34. Tuskegee: From science to conspiracy to metaphor
35. Under the shadow of Tuskegee: African Americans and health care
36. The Multicenter AIDS Cohort Study: Retention after 9-1/2 years
37. HIV drug adherence: Special situations
38. Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial
39. Adherence as a particular issue with protease inhibitors
40. Adherence: A necessity for successful HIV combination therapy